Search

everythinglearnresearchcommunity

for

Search:↓

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Progesterone can reduce seizures without relying on the GABAA receptor pathway.

Prostaglandin D2 increases testosterone levels in skin cells through reactive oxygen species, not enzymes, which could lead to new hair loss treatments.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Disrupting a specific protein's function in hair follicle stem cells triggers their activation and a self-healing process.

Neurosteroids affect prolactin levels in sheep differently depending on stress and pregnancy conditions.

The CRABP I gene in cashmere goats is highly conserved but has unique features at specific amino sites.

ROOT HAIR SPECIFIC 10 (RHS10) reduces the length of root hairs in Arabidopsis plants.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Increased PHGDH expression causes early melanin buildup in hair follicles.

PDGF signaling is crucial for maintaining and renewing hair follicle stem cells, which could help treat hair loss.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

AGD1's PH domain is essential for its role in root hair growth and polarity.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Physalis peruviana extract is more effective in treating benign prostatic hyperplasia in rats than finasteride and terazosine.

Higher ꝩ-GCS enzyme levels in PCOS patients may play a role in the disease.

Spermidine may help reduce hair loss and deserves further testing as a treatment.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Ptprq has multiple forms that change during inner ear development.

Oleuropein increases IGF-1 levels in mouse skin.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

GI197111X is best dissolved in Capmul MCM for trials.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

A natural steroid in the body may protect against eye damage in glaucoma.